Search results
Special education students still struggling with pandemic's setbacks
Newsday· 12 hours ago"She was totally out of sync," said Clark, adding that even after Brianna returned to school in the...
Foolishness and faux pas: The 2024 Niceley Awards
Tennessee Lookout via Yahoo News· 2 days agoEach legislative session, we can count on state lawmakers to pass a host of unnecessary and sometimes harmful legislation — with beneficial measures...
Apodaca: The nation's grade schools face one problem above all others
Los Angeles Times· 3 days agoIn-person learning is crucial to student development, but chronic absenteeism remains stubbornly...
Pfizer’s 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low
Forbes· 4 days agoThe company affirmed its full-year 2024 guidance of $58.5 billion to $61.5 billion in sales and...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 3 days agoThe RS Rating measures a stock's 12-month running performance against all other stocks. That RS...
Why Pinterest Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket - Pinterest...
Benzinga· 3 days agoShares of Pinterest, Inc PINS rose sharply in today's pre-market trading following strong...
These Stocks Are Moving the Most Today: Carvana, Fastly, Peloton, Wayfair, Qualcomm, Moderna,...
Barrons.com· 2 days agoCarvana posts a surprise first-quarter profit, Fastly stock sinks after the company issues guidance...
REUTERS NEWS SCHEDULE AT 10:00 a.m. GMT/ 6:00 a.m. ET
Reuters via Yahoo Finance· 3 days agoInvestors will closely watch any changes to the drugmaker's 2024 forecast, especially for COVID-19 vaccine and antiviral treatment Paxlovid. Fcus will also be on the performance ...
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
CNBC· 3 days agoThe company now expects to book adjusted earnings of $2.15 to $2.35 per share for the fiscal year,...
Earnings call: Daiichi Sankyo posts strong FY 2023 results, plans growth By Investing.com
Investing.com· 5 days agoThe pharmaceutical company's strong performance was primarily driven by robust sales of its key...
